Candida Albicans: Symptoms, Causes and Treatment Options
Leon A. Dietrich (Editor)
Tim S. Friedmann (Editor)
Series: Allergies and Infectious Diseases
BISAC: MED022090
Details
Infections due to the Candida species are the most common among fungal infections. Candida albicans is a yeast normally found as part of the skin microbiota, mouth, intestinal tract and vagina. Certain illnesses, stress, or medications can cause the out of control growth of Candida, producing infections that range from superficial to the systemic level, and potentially life-threatening diseases.
In this book, the authors discuss the symptoms, causes and treatment options of Candida albicans including the role of Candida albicans biofilms in human disease; new developments in the pathogenesis of Candida albicans; a drug delivery approach for the treatment of Candida albicans; proteins and peptides as potential antifungals for treating Candida albicans infections; antifungal therapy of candidiasis with Amphotericin B; Candida albicans infection in the lower respiratory tract among HIV/AIDs patients in Nigeria; risk factors for vaginal candidiasis; symptomatology and therapy in candidiasis; microbial inactivation of the pathogen Candida albican in marine ecosystems; polyenes, azoles, and echinocandins for treating infections caused by Candida albicans and other Candida species; and new aspects of pathogenicity, interaction to antifungals, biofilms and preventive anti-Candida strategies. (Imprint: Nova Biomedical )
Preface
The Role of Candida albicans Biofilms in Human Disease
(Emily P. Fox, Clarissa J. Nobile, Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA, and others)
New Developments in the Pathogenesis of Candida albicans: Characterization of Secreted Aspartic Proteases and Profiling of Survival Mechanism in Blood
(Wataru Aoki, Mitsuyoshi Ueda, Japan Society for the Promotion of Science, Sakyo-ku, Kyoto, Japan, and others)
A Drug Delivery Approach for the Treatment of Candida albicans
(María J. Martín Villena, Beatriz Clares Naveros, Pharmacy and Pharmaceutical Technology Department. Faculty of Pharmacy, University of Granada, Campus of Cartuja, Granada, Spain)
Proteins and Peptides as Potential Antifungals for Treating Candida albicans Infections
(Tzi Bun Ng, Jack Ho Wong, Charlene Cheuk Wing Ng, School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, New Territories, Hong Kong, China)
Antifungal Therapy of Candidiasis with Amphotericin B: New Formulation for an Old Drug
(Lamia Belkherroubi-Sari, Laboratoire Antibiotiques Antifongiques: Physicochimie Synthèse et Activité Biologique, University of Tlemcen, Tlemcen, Algeria)
Candida albicans Infection in Cases of Lower Respiratory Tract Infections among HIV/AIDS Patients in Calabar, Nigeria
(O.M. Ogba, L.N. Abia-Bassey, J. Epoke, Department of Medical Microbiology/Parasitology, University of Calabar Teaching, Hospital, Calabar, Nigeria, and others)
Laboratory Diagnosis of Vulvovaginal Candidosis
(S.I. Nwadioha, E.O.P. Nwokedi, M.S. Odimayo, G.T.A. Jombo, I. Onwuezobe, Department of Medical Microbiology & Parasitology, College of Health Sciences, Benue State University, Makurdi, Nigeria, and others)
Symptomatology and Therapy in Candidiasis
(Reginaldo G. Lima-Neto, Danielle P.C. Macedo, Rejane P. Neves, Department of Tropical Medicine, Health Sciences Center, Federal University of Pernambuco (UFPE), Cidade Universitária, Recife,PE, Brazil, and others)
Microbial Inactivation of the Pathogen Candida albicans in Marine Ecosystems
(Monia El Bour, Imen Boukef Ben Omrane, Abdellatif Boudabous, National Institute of Sea Sciences and Technologies, Tunisia, and others)
Polyenes, Azoles and Echinocandins for Treating Infections Caused by Candida albicans and other Candida Species
(Tzi Bun Ng, Jack Ho Wong, Charlene Cheuk Wing Ng, School of Biomedical Sciences, Faculty of Medicine,The Chinese University of Hong Kong, New Territories, Hong Kong, China)
Candida albicans: New Aspects of Pathogenicity, Interaction to Antifungals, Biofilms and Preventive Anti-Candida Strategies - The Overview of Own Works
(V.M. Lakhtin, M.V. Lakhtin, A.L. Bajrakova, S.S. Afanasiev, Department of Medical Biotechnology, G.N. Gabrichevsky Research Institute for Epidemiology & Microbiology, Moscow, Russia)
Vaginal Candidiasis and its Risk Factors among Women Attending a Nigerian Teaching Hospital
(S.I. Nwadioha, E.O.P. Nwokedi, J. Egesie, H. Enejuo, Department of Medical Microbiology & Parasitology, College of Health Sciences, Benue State University, Makurdi, Nigeria, and others)
Index
You have not viewed any product yet.
